Arcutis Biotherapeutics, Inc. short interest in 2021
In 2021, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 3.79% of shares outstanding on 15 Jan 2021 to 4.21% on 31 Dec 2021, a change of +0.42 percentage points. The year's high was 4.65% on 14 May 2021 and its low 2.82% on 12 Feb 2021, averaging 4.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.83 days on 29 Oct 2021. Full history: Arcutis Biotherapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 3.79% (15 Jan 2021)
- End of year
- 4.21% (31 Dec 2021)
- Change
- +0.42 pp
- High
- 4.65% (14 May 2021)
- Low
- 2.82% (12 Feb 2021)
- Average
- 4.00%
- Highest days to cover
- 26.83 (29 Oct 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 3.79% | 23.96 | |
| 29 Jan 2021 | 3.47% | 7.61 | |
| 12 Feb 2021 | 2.82% | 2.46 | results (8-K) |
| 26 Feb 2021 | 2.84% | 5.54 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 3.12% | 8.52 | |
| 31 Mar 2021 | 3.71% | 9.93 | |
| 15 Apr 2021 | 3.96% | 13.93 | |
| 30 Apr 2021 | 3.95% | 18.04 | |
| 14 May 2021 | 4.65% | 5.75 | results (8-K), 10-Q filed |
| 28 May 2021 | 4.60% | 12.67 | |
| 15 Jun 2021 | 4.53% | 18.53 | |
| 30 Jun 2021 | 4.50% | 7.49 | |
| 15 Jul 2021 | 4.51% | 15.35 | |
| 30 Jul 2021 | 4.60% | 20.43 | |
| 13 Aug 2021 | 4.53% | 11.65 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 4.36% | 19.52 | |
| 15 Sep 2021 | 4.12% | 9.80 | |
| 30 Sep 2021 | 3.94% | 11.81 | |
| 15 Oct 2021 | 3.92% | 11.57 | |
| 29 Oct 2021 | 3.96% | 26.83 | |
| 15 Nov 2021 | 3.98% | 17.79 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 3.94% | 8.49 | |
| 15 Dec 2021 | 3.94% | 8.43 | |
| 31 Dec 2021 | 4.21% | 10.43 |
See also: Arcutis Biotherapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.